Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSirius Real Estate Regulatory News (SRE)

Share Price Information for Sirius Real Estate (SRE)

Share Price is delayed by 15 minutes
Get Live Data
94.30    0.05 (0.05%)
Bid:
94.25
Ask:
94.45
Spread: 0.20 (0.212%)
Market Cap: £1.49b
SRE Live PriceLast checked at - London Stock Exchange

Intraday Sirius Real Estate Share Chart

Trading Statement

2 Oct 2013 07:00

RNS Number : 4822P
Sirius Real Estate Limited
02 October 2013
 



 

 

Sirius Real Estate Limited

("Sirius" or "the Company")

 

Trading Update

Sirius Real Estate Limited is pleased to provide the following update for the six months to 30 September 2013 ("the period").

This has been another good period for the business with the Company expected to be trading in line with management expectations for the first six months of the financial year. Overall demand for space has remained constant from our core SME market which stands to benefit from an improving economic outlook in Germany.

The Company has also made good progress towards completing the refinancing of the group. As announced in August 2013, the Company's major bank facility with Berlin Hannoversche Hypothekenbank AG ('BerlinHyp') of €208m was reduced when Sirius raised long term financing of €52 million through a bond issue secured against four of the assets from the BerlinHyp security pool. Sirius also raised €6.5 million through a share placing to pay down the BerlinHyp debt and permit the release of the four assets. Additionally, we are pleased to announce that the €4m of the bond issue for which Sirius initially subscribed, has now been sold on to third parties. As at 30 September 2013, following the bond issue, share placing and after scheduled amortisation payments, the BerlinHyp loan stood at €149.4 million. We are making good progress on refinancing the remainder of this debt on a long-term basis.

The Company's other loan facility is with ABN AMRO, a part of the Royal Bank of Scotland ('RBS'), which the Company has successfully reduced to €31.3 million, down from €49.2 million as at 31 March 2013. Under a new repayment plan, RBS has agreed, in principle, to extend the entire loan facility to the end of November 2013 on terms similar to previous extensions and has also given Sirius an option to extend the last €5 million of the loan facility until the end of February 2014. The Company intends to repay the outstanding amounts through a combination of refinancing and cash generated from the disposals of non-core properties. The final €5 million loan is expected to be secured against a single asset which is currently being marketed for sale in separate lots.

The Company looks forward to providing a more detailed trading update in December 2013 when it will announce its half yearly results for the six months to 30 September 2013.

 

 

Enquiries:

Sirius

Andrew Coombs, CEO +49 (0)30 285010110

Alistair Marks, CFO

 

Peel Hunt

Capel Irwin +44 (0)20 7418 8900

Hugh Preston

 

Novella Communications

Tim Robertson +44 (0)20 3151 7008

Ben Heath

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBFLLBXBFXFBV
Date   Source Headline
1st Mar 201812:45 pmRNSTotal Voting Rights
23rd Jan 201810:30 amRNSHolding(s) in Company
22nd Jan 201810:45 amRNSDirector/PDMR Shareholding
19th Jan 20189:30 amRNSAdmission of Scrip Shares and Circular Update
18th Jan 20181:00 pmRNSDirector Declaration
12th Jan 20181:00 pmRNSAllotment of Scrip Dividend
10th Jan 20182:00 pmRNSDirector/PDMR Shareholding
4th Jan 20187:00 amRNSAcquisition of Business Park
3rd Jan 20181:30 pmRNSTotal Voting Rights
4th Dec 20177:00 amRNSAcquisition update
1st Dec 20173:00 pmRNSScrip Dividend Reference Price and Conversion Rate
29th Nov 20172:15 pmRNSDirector/PDMR Shareholding
27th Nov 20177:01 amRNSDirectorate Change
27th Nov 20177:00 amRNSHalf-year Report
14th Nov 20173:20 pmRNSMeasurement Criteria for Trading Statements
13th Nov 20178:00 amRNSDual Primary Listing
7th Nov 201712:00 pmRNSChange of Auditor
27th Oct 20179:30 amRNSHolding(s) in Company
20th Oct 20173:30 pmRNSDirector/PDMR Shareholding
9th Oct 20177:00 amRNSTrading Statement
27th Sep 20179:45 amRNSHolding(s) in Company
26th Sep 20179:45 amRNSHolding(s) in Company
22nd Sep 20174:20 pmRNSResult of AGM
19th Sep 201710:45 amRNSHolding(s) in Company
11th Sep 201711:15 amRNSHolding(s) in Company
4th Sep 20177:00 amRNSAcquisition update
31st Aug 20174:01 pmRNSTotal Voting Rights
31st Aug 20174:00 pmRNSDirector/PDMR Shareholding
18th Aug 201712:00 pmRNSAdmission of Scrip Shares
14th Aug 20173:45 pmRNSNotice of AGM
11th Aug 20171:12 pmRNSDirector/PDMR Shareholding
7th Aug 201711:50 amRNSScrip Allotment
4th Aug 20171:00 pmRNSDirector/PDMR Shareholding
1st Aug 201710:00 amRNSCompany Secretary Change
28th Jul 20172:35 pmRNSPrivate Placement
24th Jul 20173:30 pmRNSDirector/PDMR Shareholding
4th Jul 20174:30 pmRNSScrip Dividend Reference Price and Conversion Rate
4th Jul 20177:00 amRNSAcquisition
29th Jun 20172:16 pmRNSHolding(s) in Company
29th Jun 20172:15 pmRNSHolding(s) in Company
26th Jun 20177:00 amRNSFinal Results
1st Jun 20179:00 amRNSUpdate on acquisitions and disposals
31st May 20177:00 amRNSChange of Adviser
24th May 201712:30 pmRNSHolding(s) in Company
3rd May 20177:00 amRNSCompletion of Munich business park sale for EUR85m
25th Apr 20177:00 amRNSCapital Markets Day
24th Apr 20177:00 amRNSHolding(s) in Company
11th Apr 20177:00 amRNSTrading Statement
29th Mar 20177:38 amRNSDirector/PDMR Shareholding
24th Mar 20173:48 pmRNSEUR11m Sale of Dusseldorf Asset

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.